Could anti-TNF therapy trigger MS?

Arthritis patients treated with TNF inhibitors may be at an increased risk of developing multiple sclerosis, according to a data linkage study from Denmark.

The researchers cross-checked data from the DANBIO registry — which captures over 90% of all Danish arthritis patients on anti-TNF therapy — with the Danish Multiple Sclerosis Registry.

Patients started on TNF inhibitors were 38% more